Case Report
Author Details :
Volume : 6, Issue : 4, Year : 2021
Article Page : 245-248
https://doi.org/10.18231/j.ijirm.2021.053
Abstract
Background: COVID-19 is a severe acute respiratory infection affecting worldwide population. There are many cases of complications after the COVID exposure occurring nowadays. One among is Post-COVID-19 Multisystem Inflammatory Syndrome in Children (MIS-C). As per CDC report till March 1, 2021, 2617 cases of MIS-C were meeting the definite case criteria and among 33 death cases were reported. Here we report a case of COVID-19 associated Multi-system inflammatory syndrome in a child (MIS-C) interpreted with WHO case definition criteria.
Case Description: The patient was a 7-year-old boy, with initial presentation of moderate fever, non-itchy red blanching rashes, breathlessness, later progressed to cardiogenic shock accompanied by positive SARS-CoV-2 antigen result.
Management: The emergency cardiogenic shock treatment protocol was followed with initial stabilization and resuscitation strategy. He was successfully managed by three days of IV Immunoglobulin 2g/kgand Methylprednisolone 2mg/kg/day therapy along with other supportive treatments. The patient was discharged after 20 days of hospital stay with improved health condition.
Conclusions: Our case report will strengthen the exposure-outcome relations between the coronavirus infection and MIS-C, moreover the strategies carried out in our case will be a future direction for the effective management of MIS-C.
Keywords: COVID19, MISC, complications of COVID19, immunoglobulin, paediatric population
How to cite : Reji R A, Jain R, Mohandas S S, Dalal V, Bali P, Post- COVID-19 multisystem inflammatory syndrome in children. IP Indian J Immunol Respir Med 2021;6(4):245-248
This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
Received : 01-09-2021
Accepted : 22-12-2021
Viewed: 1406
PDF Downloaded: 509